| Prev Close | 193.09 |
| Day Low/High | 194.50 / 199.78 |
| 52 Wk Low/High | 187.16 / 468.55 |
Biogen Inc. (BIIB)
199.65
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 146.45B |
| Market Cap | 28.28B |
| P/E Ratio | 8.89 |
| Div & Yield | N.A. (N.A) |
The Biotechs Are Back
Watch this leadership group that's been lagging.
Gilead Posting Decent Gains
Trading in February has commenced and indices started up, but have already given all of their early gains. Americans boosted their savings in December and cut spending by the largest amount in five years. Energy stocks are getting a bid today on Fri...
This Morning's Market Setup
The rundown: U.S. futures higher: S&P 500 futures +4 and Nasdaq futures are 37 handles higher -- thanks to Apple's (AAPL) blow-out quarter. European markets have flat-lined. Japan's Nikkei 225 is +0.15%. Little in the news. Within the index, energy ...
8 Signs the Market Is Remarkably Healthy
These are surefire indications of a bountiful tape.
5 Reasons I'm Becoming an America Firster
Use the overall weakness to pick up the America First stocks.
Braving Biotech
Do you need to pick one name? Biotech has carried with it a lasting resiliency like few other sectors. Perhaps it is driven by optimism and hope. Perhaps it is driven by the fear of suffering or watching someone suffer from the very illnesses these ...
Some Biotech Signals
Here's how to trade some key price relationships.
Go With What's Worked, Part 1
Throughout this historic run, four groups have consistently led the market.
Absolutely Nothing Happened
There had been no catalysts.
Cramer: Oil-and-Gas vs. Everything Else
Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.
Cramer: This Is Not 2000
A litany of reasons why you should calm your nerves.
There's a Lot Going on Under the Hood
An immense market rotation is happening.
You Have to Love Biotech
In this era of turmoil, investors can take comfort in this sector.
A Lot of Mystifying Action
It's amazing how stupid the market really is.
Don't Expect Any Apologies
Still, it's a good time to review what's happening, so we never forget.
Rules of the Game: No Slowdown in Health Care
Some growth leaders in the sector are getting technical support.
Play the Uncertainty of Market Movement
Use one short and one buy.
Bionic or Just Plain?
Checking two biotech charts. I'm sure I'm not the first to say this, but traditional valuation on the biotech names is just a mistake. Drug pricing, pipelines, trial data, patents and a few scientific words I can't pronounce are the most important f...
Signs of Leadership Returning
Biotech stocks are thriving in a slower-growth, low-inflation world.
Recommended Viewing
Take the ice bucket challenge? Fans, for the past two weeks you have been reading about the bad break I got. Yet today I consider myself the luckiest man on the face of the earth. I have been in ballparks for seventeen years and have never received ...
Off the Charts
As the action continues to the downside, we have no long positions on the table.
Off the Charts
For the first time in months, we have no long positions on the table.
Every Which Way But Short
In theory there should be plenty of shorting opportunities.
Can't Find an Edge
Too many people are willing to park cash in Microsoft or Apple.
